Alzheimer’s Disease Research Study

We are looking for individuals who have Alzheimer’s Disease for a study of an investigational medication designed to slow the progression of Alzheimer’s disease. To be eligible, participants must:

• Be 55 to 80 years of age
• Have been diagnosed with Alzheimer’s disease
• Have an MRI or CT scan that was performed after the Alzheimer’s disease diagnosis
• Have a study partner who can attend appointments

Eligible participants will receive study-related care, monitoring and investigational medication or placebo. Compensation for time and travel may be available to patient and caregiver.

For more information or to schedule a memory screening for this study, call Meridien Research today at 813-563-6009 to see if you qualify! Or complete the form below.